More on BIAF

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-1,135.3% Growth)
- Ratings (0.0 Score)

Upcoming Events

- Earnings (8/19/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

bioAffinity (NQ:BIAF)
Delayed: 0.70 -0.01 (1.41%)
Prev. Close $0.71  
Open$0.71 
52 Wk High$ 
52 Wk Low$ 
Day High$0.72 
Day Low$0.69 
P/E N/A  
EPS$ 
Volume74,805 

Friends, Peers and Foes (?): BIAFW, AIRDF, ALBC, BEEM, BHST (more...)

Jul 7, 2026 08:54 AM Form 8-K bioAffinity Technologies For: Jul 07
Jul 7, 2026 08:46 AM bioAffinity Technologies Q2 CyPath Lung sales rise over 200% year-over-year
Jul 7, 2026 08:46 AM bioAffinity Technologies’ Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues
Jun 30, 2026 05:19 PM Form 8-K bioAffinity Technologies For: Jun 30
Jun 23, 2026 03:41 PM Q2 Investor Summit Virtual Live Wednesday June 24
Jun 23, 2026 03:41 PM Q2 Investor Summit Virtual Live Wednesday June 24
Jun 22, 2026 08:01 AM bioAffinity Technologies reports preclinical siRNA findings for skin cancer
Jun 22, 2026 08:00 AM bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells
Jun 18, 2026 05:07 PM Form 8-K bioAffinity Technologies For: Jun 16
Jun 18, 2026 02:55 PM WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering
View All Articles

Entities mentioned with BIAF

View All Entities